Gabrail Cancer Research Center is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Gabrail Cancer Research Center has participated in 10 clinical trials with 3 currently active.
Therapeutic areas: Non-Small-Cell Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor.
Sponsors: BioAtla, Inc., Turning Point Therapeutics, Inc., Pierre Fabre Medicament.
Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gabrail Cancer Research Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gabrail Cancer Research Center has 10 clinical trials on record, with 3 currently active. Their work covers Non-Small-Cell Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor.
Gabrail Cancer Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.